Valsartan/Amlodipine Tablet 5/80 mg
Amlodipine Besylate · Valsartan
Prescription medication · Combination
Dongwha Pharmaceutical Co., Ltd.
MFDS item code 201308536 · Approved 2013.07.30
This product's status changed to Expired on 2023.07.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension not controlled with monotherapy
This medication is used for patients with essential hypertension who have difficulty controlling blood pressure with either amlodipine or valsartan monotherapy alone. Maintaining blood pressure within the normal range is important for essential hypertension, and this medication effectively lowers blood pressure, helping to reduce the risk of cardiovascular disease. Therefore, this medication assists in the management of hypertension and improves blood pressure control.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction or cholestasis. Patients aged 65 years or older: Caution should be exercised when increasing the dose.
Pediatrics: The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. It should not be used in patients with allergies to any of the active ingredients or similar classes of drugs, as well as in pregnant or breastfeeding women and patients with severe kidney or liver disorders. Patients who are sodium or fluid depleted may experience hypotension, so their condition should be carefully checked before starting the medication, and blood pressure and symptoms should be closely monitored during use. Patients with high potassium levels or taking medications that can raise potassium levels should have their potassium levels frequently checked and monitored. Patients with renal vascular problems or those who have had a kidney transplant should also use this medication cautiously as kidney function may worsen. If angioedema occurs while taking this medication, it should be discontinued immediately, and it should not be restarted. Patients with heart failure or those recovering from a myocardial infarction should use this medication cautiously according to a doctor's advice due to the risk of changes in kidney function and hypotension. Dizziness or fatigue may occur while taking this medication, so caution is needed when driving or operating machinery. Interactions may occur when taken with other antihypertensive medications, potassium supplements, diuretics, or non-steroidal anti-inflammatory drugs (NSAIDs), so consultation with a physician or pharmacist is recommended. It is not recommended for children as safety and effectiveness have not been adequately established.
Pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, fainting, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, sweating, itching, joint swelling, low back pain, arthritis, muscle spasms, lethargy, polyuria, nocturia, erectile dysfunction, edema, localized edema, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, hemoglobin decrease, hematocrit decrease, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory loss, dysgeusia, peripheral neuropathy, muscle rigidity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urological disorders, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neurosensitivity, sensory loss, Stevens-Johnson syndrome, itching, peripheral edema, hypotension
Not everyone experiences these, and they can vary from person to person.
This medication should be stored tightly closed in a container that prevents air or moisture from entering. A storage temperature of 1 to 30 degrees Celsius at room temperature is recommended.
Dark yellow round film-coated tablet
28 tablets (14 tablets/Alu-AluX2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Amlodipine Besylate · Valsartan
Prescription medication · Combination
Dongwha Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.